Potentially Curable Cancers of the Esophagus and Stomach

Area of Science:

• Oncology
• Gastroenterology

Background:

• Gastric and gastroesophageal adenocarcinomas represent a major global health burden, ranking as the third leading cause of cancer death.
• Limited effective treatment regimens exist for metastatic disease, contributing to poor patient outcomes.
• Despite numerous efforts, progress in treating these cancers has been slow compared to other solid tumors, with incomplete molecular profiling.

Purpose of the Study:

• To review the current literature on the management of localized gastric and gastroesophageal cancers.
• To explain key principles guiding therapy for patients with localized disease.
• To explore future opportunities for novel treatments and personalized medicine.

Main Methods:

• Literature review of current management strategies for localized gastric and gastroesophageal cancers.
• Analysis of principles that guide therapeutic decisions.
• Discussion of emerging opportunities based on molecular profiling and immunotherapy.

Main Results:

• Localized gastric and gastroesophageal cancers necessitate a multidisciplinary approach for optimal management.
• Current treatment regimens for metastatic disease are limited and modestly effective.
• In-depth molecular profiling data is still lacking for these cancers.

Conclusions:

• A multidisciplinary approach is crucial for managing localized gastric and gastroesophageal cancers.
• Future research will leverage The Cancer Genome Atlas data to identify novel therapeutic targets and drugs.
• Harnessing the immune system and customizing therapy hold promise for improved patient outcomes.